TB Alliance Announces Four Drug Discovery Collaborations
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
Anacor Pharmaceuticals today announced that it has entered into a license and research agreement with the Global Alliance for TB
Global Health Technologies Coalition receives funding to encourage new health solutions for the developing world Washington, DC, USA, May 15,
On March 24, 2009 the TB Alliance Community Engagement Program sponsored Community Advisory Boards (CABs) at four REMoxTB clinical trial
Chinese researchers will work with a US-based product development partnership in a bid to develop new tuberculosis drugs from ingredients
Institute of Microbiology (IMCAS), a member institute of the Chinese Academy of Sciences, and the Global Alliance for TB Drug
The discovery of new oral treatments for Tuberculosis (TB), which could save millions of lives in developing countries, will receive
A government minister will today challenge drug companies to help the developing world by giving up their patent rights to
Tuberculosis (TB) awareness will receive a boost on World TB Day (March 24), and beyond, in the form of a
Launched in 2008 as a two-year campaign, I am stopping TB is, again, the theme of World TB Day 2009.